Advertisement

Archives of Dermatological Research

, Volume 305, Issue 5, pp 423–432 | Cite as

Identification of steroid sensitive responders versus non-responders in the treatment of keloid disease

  • Sara Ud-Din
  • Alison Bowring
  • Barbara Derbyshire
  • Julie Morris
  • Ardeshir Bayat
Original Paper

Abstract

Intralesional corticosteroid injection is a well-recognised treatment modality for keloid disease (KD). Approximately 50 % of KD cases are considered non-responders (or steroid resistant) with no consensus or indicators in detecting steroid-sensitive cases. In view of the undesirable side effects, uncertainty in timing and regularity of steroid treatment, we planned to identify responders and non-responders to target treatment more effectively. A scar injection proforma was developed capturing a detailed history focusing on symptoms and signs (redness, appearance, contour, texture, distortion and severity) associated with KD. The cause, site, number of keloid scars and scar recurrence were recorded as the lesions were injected on a monthly basis. A detailed description of response to steroid injection was documented and photographs were taken. Demographic data were collected on 65 patients (11 to 74 years with mean age 34.7 years, 60 % were females, 50 % were Caucasian). 77 % (n = 50) were classified as steroid responders and showed improvement in symptoms and signs within 3 months. There was a statistically significant correlation between patients with higher contour scores of KD prior to treatment (p = 0.013) and frequency of injections (p = 0.003). Thus, the odds of being a responder were greater for patients with more than one injection and with higher contour scores. This preliminary case series has provided early evidence in enabling identification of steroid responders versus non-responders within a 3-month period. Selection of KD non-responders to steroid treatment can avoid potentially painful injection, its subsequent side effects and unnecessary continuation of redundant therapy and follow-up.

Keywords

Steroid injection Triamcinolone acetonide Raised dermal scarring Steroid sensitivity Responders Non-responders Keloid disease Hypertrophic scars 

References

  1. 1.
    Ardehali B, Nouraei SA, Van Dam H, Dex E, Wood S, Nduka C (2007) Objective assessment of keloid scars with three-dimensional imaging: quantifying response to intralesional steroid therapy. Plast Reconstr Surg 119:556–561CrossRefPubMedGoogle Scholar
  2. 2.
    Asilian A, Darougheh A, Shariati F (2006) New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg 32:907–915CrossRefPubMedGoogle Scholar
  3. 3.
    Atiyeh BS (2007) Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices and emerging methods. Aesthet Plast Surg 31:468–492CrossRefGoogle Scholar
  4. 4.
    Bayat A, McGrouther D, Ferguson M (2003) Skin scarring. BMJ 326:88–92CrossRefPubMedGoogle Scholar
  5. 5.
    Beausang E, Floyd H, Dunn KW, Orton CI, Ferguson MW (1998) A new quantitative scale for clinical scar assessment. Plast Reconstr Surg 102:1954–1961CrossRefPubMedGoogle Scholar
  6. 6.
    Beranak JT (1997) Silicone gel sheeting for the management of hypertrophic and keloids scars: the mechanism of its action. Dermatol Surg 23:401–405Google Scholar
  7. 7.
    Berman B, Flores F (1999) Comparison of a silicone gel-filled cushion and silicone gel sheeting for the treatment of hypertrophic or keloid scars. Dermatol Surg 25:484–486CrossRefPubMedGoogle Scholar
  8. 8.
    Boutli-Kasapidou F, Tsakiri A, Anagnostou E, Mourellou O (2005) Hypertrophic and keloidal scars: an approach to polytherapy. Int J Dermatol 44:324–327CrossRefPubMedGoogle Scholar
  9. 9.
    Boyadjiev C, Popchristova E, Mazgalova J (1995) Histomorphologic changes in keloids treated with Kenacort. J Trauma 38:299–302CrossRefPubMedGoogle Scholar
  10. 10.
    Brent B (1978) The role of pressure therapy in management of earlobe keloids: preliminary report of a controlled study. Ann Plast Sur 1:579–581CrossRefGoogle Scholar
  11. 11.
    Brown BC, McKenna SP, Siddhi K, McGrouther DA, Bayat A (2008) The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg 61:1049–1058CrossRefPubMedGoogle Scholar
  12. 12.
    Brown BC, McKenna SP, Solomon M, Wilburn J, McGrouther DA, Bayat A (2010) The patient-reported impact of scars measure: development and validation. Plast Reconstr Surg 125:1439–1449CrossRefPubMedGoogle Scholar
  13. 13.
    Brown BC, Moss TP, McGrouther DA, Bayat A (2010) Skin scar preconceptions must be challenged: importance of self-perception in skin scarring. J Plast Reconstr Aesthet Surg 63:1022–1029CrossRefPubMedGoogle Scholar
  14. 14.
    Conejo-Mir JS, Corbi R, Linares R (1998) Carbon dioxide laser ablation associated with interferon alfa-2b injection reduces the recurrence of keloids. J Am Acad Dermatol 39:1039–1040CrossRefPubMedGoogle Scholar
  15. 15.
    Converse JM, Stallings JO (1972) Eradication of large auricular keloids by excision, skin grafting, and intradermal injection of triamcinolone acetonide solution. Case report. Plast Reconstr Surg 49:461–463CrossRefPubMedGoogle Scholar
  16. 16.
    Cruz NI, Korchin L (1994) Inhibition of human keloid fibroblast growth by isotretinoin and triamcinolone acetonide in vitro. Ann Plast Surg 33:401–405CrossRefPubMedGoogle Scholar
  17. 17.
    Darougheh A, Asilian A, Shariati F (2007) Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Clin Exp Dermatol 34:219–223CrossRefGoogle Scholar
  18. 18.
    Darzi MA, Chowdri NA, Kaul SK, Khan M (1992) Evaluation of various methods of treating keloids and hypertrophics scars: a 10-year follow-up study. Br J Plast Surg 45:374–379CrossRefPubMedGoogle Scholar
  19. 19.
    Donkor P (2007) Head and neck keloid: treatment by core excision and delayed intralesional injection of steroid. J Oral Maxillofac Surg 65:1292–1296CrossRefPubMedGoogle Scholar
  20. 20.
    Fitzpatrick RE (1999) Treatment of inflamed hypertrophic scars using intralesional 5FU. Dermatol Surg 25:224–232CrossRefPubMedGoogle Scholar
  21. 21.
    Gangemi EN, Gregori D, Berchialla P et al (2008) Epidemiology and risk factors for pathologic scarring after burn wounds. Arch Facial Plast Surg 10:93–102CrossRefPubMedGoogle Scholar
  22. 22.
    Hollywood KA, Maatje M, Shadi IT, Henderson A, McGrouther DA (2010) Phenotypic profiling of keloid scars using FT-IR microspectroscopy reveals a unique spectral signature. Arch Dermatol Res 302:705–715CrossRefPubMedGoogle Scholar
  23. 23.
    Iqbal SA, Sidgwick GP, Bayat A (2012) Identification of fibrocytes from mesenchymal stem cells in keloid tissue: a potential source of abnormal fibroblasts in keloid scarring. Arch Dermatol Res 304:665–671CrossRefPubMedGoogle Scholar
  24. 24.
    Jalali M, Bayat (2007) Current use of steroids in management of abnormal raised skin scars. Surgeon 5:175–180CrossRefPubMedGoogle Scholar
  25. 25.
    Kill J (1977) Keloids treated with topical injections of triamcinolone acetonide (kenalog): immediate and long-term results. Scand J Plast Reconstr Surg 11:169–172CrossRefGoogle Scholar
  26. 26.
    Koc E, Arca E, Surucu B, Kurumlu Z (2008) An open, randomized, controlled, comparative study of the combined effect of intralesional triamcinolone acetonide and onion extract gel and intralesional triamcinolone acetonide alone in the treatment of hypertrophic scars and keloids. Dermatol Surg 34:1507–1514CrossRefPubMedGoogle Scholar
  27. 27.
    Krusche T, Worret WI (1995) Mechanical properties of keloids in vivo during treatment with intralesional triamcinolone acetonide. Arch Dermatol Res 287:289–293CrossRefPubMedGoogle Scholar
  28. 28.
    Larrabee WF, East CA, Jaffe HS, Stephensen C, Peterson KE (1990) Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg 116:1159–1162CrossRefPubMedGoogle Scholar
  29. 29.
    Layton AM, Yip J, Cunliffe WJ (1994) A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol 130:498–501CrossRefPubMedGoogle Scholar
  30. 30.
    Lee Y, Minn KW, Baek RM, Hong JJ (2001) A new surgical treatment of keloid: keloid core excision. Ann Plast Surg 46:135–140CrossRefPubMedGoogle Scholar
  31. 31.
    Leventhal D, Furr M, Reiter D (2006) Treatment of keloids and hypertrophic scars. Arch Facial Plast Surg 8:362–368CrossRefPubMedGoogle Scholar
  32. 32.
    Low SQ, Moy RL (1992) Scar war strategies. Target collagen. J Dermatol Surg Oncol 18:981–986CrossRefPubMedGoogle Scholar
  33. 33.
    Manuskiatti W, Fitzpatrick RE (2002) Treatment response of keloidal and hypertrophic sternotomy scars. Comparison among intralesional corticosteroid, 5-fluorouracil, and 585 nm flashlamp-pumped pulsed dye laser treatments. Arch Dermatol 138:1149–1155CrossRefPubMedGoogle Scholar
  34. 34.
    McCoy BJ, Diegelmann RF, Cohen IK (1980) In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide. Proc Soc Exp Biol Med 163:216–222PubMedGoogle Scholar
  35. 35.
    Mustoe TA, Cooter RD, Gold MH et al (2002) International clinical recommendations on scar management. Plast Reconstr Surg 110:560–571CrossRefPubMedGoogle Scholar
  36. 36.
    Nedelec B, Shankowsky H, Tredget E (2000) Rating the resolving hypertrophic scar: comparison of the Vancouver Scar Scale and scar volume. J Burn Care Rehabil 21:205CrossRefPubMedGoogle Scholar
  37. 37.
    Ragoowansi R, Cornes PGS, Glees JP, Powell BW, Moss AL (2001) Ear-lobe keloids: treatment by a protocol of surgical excision and immediate postoperative adjuvant radiotherapy. Br J Plast Surg 54:504–508CrossRefPubMedGoogle Scholar
  38. 38.
    Rahban S, Garner W (2003) Fibroproliferative scars. Clin Plast Surg 30:77–89CrossRefPubMedGoogle Scholar
  39. 39.
    Reed BR, Clark RA (1985) Cutaneous tissue repair: practical implications of current knowledge, II. J Am Acad Dermatol 13:919–941CrossRefPubMedGoogle Scholar
  40. 40.
    Robles D, Moore E, Draznin M, Berg D (2007) Keloids: patho-physiology and management. Dermatol Online J 13:9PubMedGoogle Scholar
  41. 41.
    Roques C, Teot L (2008) The use of corticosteroids to treat keloids: a review. Int J Low Extrem Wounds 7:137–145CrossRefPubMedGoogle Scholar
  42. 42.
    Sadeghinia A, Sadeghinia S (2012) Comparison of the efficacy of intralesional triamcinolone acetonide and 5-fluorouracil tattooing for the treatment of keloids. Dermatol Surg 38:104–109CrossRefPubMedGoogle Scholar
  43. 43.
    Salvarani C, Cantini F, Olivieri I, Barozzi L, Macchioni L, Boiardi L, Niccoli L, Padula A, Pulsatelli L, Meliconi R (2000) Corticosteroid injections in polymyalgia rheumatica: a double-blind, prospective, randomized, placebo controlled study. J Rheumatol 27:1470–1476PubMedGoogle Scholar
  44. 44.
    Seifert O, Mrowietz U (2009) Keloid scarring: bench and bedside. Arch Dermatol Res 301:259–272CrossRefPubMedGoogle Scholar
  45. 45.
    Shih B, Bayat A (2010) Genetics of keloid scarring. Arch Dermatol Res 302:319–339CrossRefPubMedGoogle Scholar
  46. 46.
    Shih B, Bayat A (2012) Comparative genomic hybridisation analysis of keloid tissue in Caucasians suggests possible involvement of HLA-DRB5 in disease pathogenesis. Arch Dermatol Res 304:241–249CrossRefPubMedGoogle Scholar
  47. 47.
    Singer AJ, Clark RA (1999) Cutaneous wound healing. N Engl J Med 341:738–746CrossRefPubMedGoogle Scholar
  48. 48.
    Sund B (2000) New developments in wound care. PJB Publications, LondonGoogle Scholar
  49. 49.
    Syed F, Bayat A (2013) Superior effect of combination vs. single steroid therapy in keloid disease: a comparative in vitro analysis of glucocorticoids. Wound Repair Regen 21:88–102CrossRefPubMedGoogle Scholar
  50. 50.
    van Zuijlen P, Angeles A, Kreis R, Bos KE, Middlekoop E (2002) Scar assessment tools: implications for current research. Plast Reconstr Surg 109:1108CrossRefPubMedGoogle Scholar
  51. 51.
    Wu WS, Wang FS, Yang KD, Huang CC, Kuo YR (2006) Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation. J Invest Dermatol 126:1264–1271CrossRefPubMedGoogle Scholar
  52. 52.
    Yosipovitch G, Widijanti Sugeng M, Goon A, Chan YH, Goh CL (2001) A comparison of the combined effect of cryotherapy and corticosteroid injections versus corticosteroids and cryotherapy alone on keloids: a controlled study. J Dermatol Treat 12:87–90CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Sara Ud-Din
    • 1
    • 2
  • Alison Bowring
    • 1
    • 2
  • Barbara Derbyshire
    • 2
  • Julie Morris
    • 3
  • Ardeshir Bayat
    • 1
    • 2
  1. 1.Plastic and Reconstructive Surgery Research, Manchester Institute of BiotechnologyUniversity of ManchesterManchesterUK
  2. 2.University Hospital of South Manchester NHS Foundation Trust, Faculty of Medical and Human Sciences, Manchester Academic Health Science Centre, Institute of Inflammation and RepairUniversity of ManchesterManchesterUK
  3. 3.Medical StatisticsUniversity Hospital South ManchesterManchesterUK

Personalised recommendations